Gilder Gagnon Howe & Co’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-15,241
| Closed | -$1.41M | – | 263 |
|
|
2025
Q4 | $1.41M | Sell |
15,241
-2,359
| -13% | -$226K | 0.01% | 208 |
|
|
2025
Q3 | $1.31M | Sell |
17,600
-74,156
| -81% | -$7.51M | 0.01% | 206 |
|
|
2025
Q2 | $11.9M | Sell |
91,756
-91,897
| -50% | -$13.3M | 0.13% | 101 |
|
|
2025
Q1 | $29.3M | Sell |
183,653
-4,040
| -2% | -$731K | 0.38% | 71 |
|
|
2024
Q4 | $34.8M | Sell |
187,693
-35,433
| -16% | -$6.88M | 0.38% | 64 |
|
|
2024
Q3 | $47.1M | Sell |
223,126
-17,535
| -7% | -$3.05M | 0.56% | 47 |
|
|
2024
Q2 | $32.2M | Sell |
240,661
-10,062
| -4% | -$1.9M | 0.4% | 65 |
|
|
2024
Q1 | $53.9M | Sell |
250,723
-5,237
| -2% | -$1.03M | 0.67% | 42 |
|
|
2023
Q4 | $52.1M | Sell |
255,960
-207,134
| -45% | -$33.6M | 0.71% | 42 |
|
|
2023
Q3 | $91.9M | Sell |
463,094
-32,959
| -7% | -$8.31M | 1.4% | 21 |
|
|
2023
Q2 | $161M | Sell |
496,053
-15,620
| -3% | -$4.46M | 2.2% | 8 |
|
|
2023
Q1 | $120M | Sell |
511,673
-25,096
| -5% | -$6.34M | 1.98% | 12 |
|
|
2022
Q4 | $135M | Sell |
536,769
-64,736
| -11% | -$13.8M | 2.52% | 9 |
|
|
2022
Q3 | $107M | Sell |
601,505
-3,876
| -0.6% | -$779K | 1.86% | 10 |
|
|
2022
Q2 | $111M | Sell |
605,381
-47,764
| -7% | -$9.53M | 1.97% | 8 |
|
|
2022
Q1 | $168M | Sell |
653,145
-134,604
| -17% | -$30.8M | 1.55% | 11 |
|
|
2021
Q4 | $181M | Sell |
787,749
-9,503
| -1% | -$2.32M | 1.03% | 25 |
|
|
2021
Q3 | $186M | Buy |
797,252
+21,286
| +3% | +$4.44M | 0.96% | 28 |
|
|
2021
Q2 | $150M | Sell |
775,966
-78,716
| -9% | -$15.6M | 0.74% | 43 |
|
|
2021
Q1 | $177M | Sell |
854,682
-110,474
| -11% | -$23.5M | 0.95% | 26 |
|
|
2020
Q4 | $182M | Sell |
965,156
-33,808
| -3% | -$5.53M | 0.9% | 27 |
|
|
2020
Q3 | $129M | Sell |
998,964
-104,385
| -9% | -$11.5M | 0.79% | 31 |
|
|
2020
Q2 | $96M | Buy |
1,103,349
+171,478
| +18% | +$13.2M | 0.75% | 39 |
|
|
2020
Q1 | $56.2M | Buy |
931,871
+422,687
| +83% | +$31.3M | 0.67% | 56 |
|
|
2019
Q4 | $37.8M | Buy |
509,184
+223,317
| +78% | +$14.4M | 0.39% | 81 |
|
|
2019
Q3 | $17.4M | Buy |
285,867
+7,112
| +3% | +$468K | 0.2% | 101 |
|
|
2019
Q2 | $16.9M | Buy |
278,755
+129,143
| +86% | +$6.96M | 0.17% | 107 |
|
|
2019
Q1 | $8.49M | Buy |
149,612
+4,898
| +3% | +$265K | 0.09% | 131 |
|
|
2018
Q4 | $6.11M | Sell |
144,714
-6,901
| -5% | -$293K | 0.09% | 140 |
|
|
2018
Q3 | $6.38M | Buy |
151,615
+11,130
| +8% | +$522K | 0.07% | 160 |
|
|
2018
Q2 | $5.01M | Buy |
+140,485
| New | +$4.53M | 0.05% | 172 |
|
Other funds holding INSP
DM
Gilder Gagnon Howe & Co's INSP Position: Q1 2026 in Review
Gilder Gagnon Howe & Co sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 15,241 shares — an estimated $1.41M sold.
Gilder Gagnon Howe & Co first reported a position in INSP in Q2 2018 and held it in 31 quarters. The position peaked at $186M in Q3 2021. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- Gilder Gagnon Howe & Co reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 15,241 Inspire Medical Systems shares in Q1 2026, an estimated $1.41M.
- Gilder Gagnon Howe & Co first reported a position in Inspire Medical Systems in Q2 2018 and held it in 31 quarters.
- Gilder Gagnon Howe & Co's Inspire Medical Systems position peaked at $186M in Q3 2021.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2026, filed 15 May 2026.